Novel proteoforms with single amino acid polymorphism represent proteins that often have altered biological functions but are less explored in the human proteome. We have developed an approach, searching high quality shotgun proteomic data against an extended protein database, to identify expressed mutant proteoforms in glioma stem cell (GSC) lines. The systematic search of MS/MS spectra has recognized 13 chromosome 19 proteins in GSCs with altered amino acid sequences using PEAKS 7.0 as the search engine. The results were further verified by manual spectral examination, validating 14 proteoforms. One of the novel findings, a mutant form of branched-chain aminoacyl transferase 2 (T186R), was verified at the transcript level and by SRM in se...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
We report progress assembling the parts list for chromosome 17 and illustrate the various processes ...
Novel proteoforms with single amino acid polymorphism represent proteins that often have altered bio...
Novel proteoforms with single amino acid variations represent proteins that often have altered biolo...
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease,...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Structural technologies are an essential component in the design of precision therapeutics. Precisio...
BackgroundOnco-proteogenomics aims to understand how changes in a cancer's genome influences its pro...
International audiencePrimary cell lines derived as neurospheres, enriched in cancer stem cells, are...
Dynamic changes in the expression of multiple genes appear to be common features that distinguish tr...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Loss of p53 function is a common event in a variety of human cancers including tumors of glial origi...
Abstract Background Onco-proteogenomics aims to under...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
We report progress assembling the parts list for chromosome 17 and illustrate the various processes ...
Novel proteoforms with single amino acid polymorphism represent proteins that often have altered bio...
Novel proteoforms with single amino acid variations represent proteins that often have altered biolo...
Glioblastoma (GBM), the most malignant of primary brain tumors, is a devastating and deadly disease,...
The 2016 WHO Classification of Tumors of the Central Nervous System separates IDH-mutant gliomas int...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Structural technologies are an essential component in the design of precision therapeutics. Precisio...
BackgroundOnco-proteogenomics aims to understand how changes in a cancer's genome influences its pro...
International audiencePrimary cell lines derived as neurospheres, enriched in cancer stem cells, are...
Dynamic changes in the expression of multiple genes appear to be common features that distinguish tr...
One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protei...
Loss of p53 function is a common event in a variety of human cancers including tumors of glial origi...
Abstract Background Onco-proteogenomics aims to under...
The goal of the Chromosome-Centric Human Proteome Project (C-HPP) is to fully provide proteomic info...
Primary brain tumors are predominantly malignant gliomas. Grade IV astrocytomas (glioblastomas, GBM)...
We report progress assembling the parts list for chromosome 17 and illustrate the various processes ...